Predicting the outcome of hepatitis C virus treatment

July 1, 2014

Millions of people throughout the world are infected with hepatitis C virus (HCV), which can lead to cirrhosis of the liver and cancer. Directly acting antiviral agents inhibit viral proteins and have been used to successfully treat HCV. Unfortunately, antiviral therapy fails in some patients, resulting in a relapse of HCV.

A study published in the Journal of Clinical Investigation identifies a marker that can identify patients likely to have an HCV relapse after . Shyamasundaran Kottilil and colleagues at the NIH evaluated the immune response of HCV-infected individuals treated with . Treated patients that had increased expression of type I interferon were more likely to remain HCV-free. Patients unable to maintain a type I interferon response were more likely to have an HCV relapse.

This study provides a potential marker to identify patients prone to HCV relapse. Moreover, these results suggest that type I interferon treatment in at-risk patients merits future study.

More information: Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome, J Clin Invest. DOI: 10.1172/JCI75938

Related Stories

Better long-term outcomes with low hep C viral load

March 25, 2013

(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of HCV, according to research ...

Hepatic decompensation higher with HIV, HCV co-infection

March 18, 2014

(HealthDay)—Patients co-infected with HIV and hepatitis C virus (HCV) have higher rates of hepatic decompensation than those with HCV monoinfection, according to a study published in the March 18 issue of the Annals of ...

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.